Eric Weisblum - 15 Apr 2019 Form 4 Insider Report for Silo Pharma, Inc. (SILO)

Role: CEO, CFO and President, Director
Signature: /s/ Eric Weisblum
Issuer symbol: SILO
Transactions as of: 15 Apr 2019
Net transactions value: +$281
Form type: 4
Filing time: 17 May 2021, 07:31:56 UTC
Next filing: 17 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SILO	Common Stock	Purchase	$115	+57,714		$0.002000^*	57,714	17 Jun 2019	Direct
transaction	SILO	Common Stock	Purchase	$76	+200	+0.35%	$0.3800	57,914	15 Oct 2019	Direct
transaction	SILO	Common Stock	Purchase	$90	+200	+0.35%	$0.4500	58,114	22 Oct 2019	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SILO	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	15 Apr 2019	Common Stock	100,000	$0.000100	Direct	F1
transaction	SILO	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	15 Apr 2019	Common Stock	100,000	$0.000100	Direct	F1, F2
transaction	SILO	Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	15 Oct 2019	Common Stock	100,000	$0.000100	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019.
F2	The options were granted on April 15, 2019 and vested in full on July 15, 2019.